AEON Biopharma
AEON
AEON
26 hedge funds and large institutions have $103M invested in AEON Biopharma in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.03% more ownership
Funds ownership: 0.32% → 0.35% (+0.03%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$6.37M | |
| 2 | +$1.75M | |
| 3 | +$649K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$648K |
| 5 |
State Street
Boston,
Massachusetts
|
+$574K |
Top Sellers
| 1 | -$2.32M | |
| 2 | -$11.7K | |
| 3 | -$4.67K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$4.18K |
| 5 |
DCM
Dupont Capital Management
Wilmington,
Delaware
|
-$22 |